Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

Every year, more than 5 million people in the U.S. are diagnosed with heart valve disease, but this condition has no ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Growing up with a heart disease, Ashley Pecora never knew what her life was going to look like—until two years ago when she ...

Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices.

Connecticut U.S. Rep. John Larson, who inexplicably stopped speaking during a speech Monday on the House of Representatives floor, said Tuesday night he had suffered a complex ...